Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BioAtla, Inc.BCAB · Entity 879 | Director · Chief Executive Officer | August 31, 2026 | September 02, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BioAtla, Inc.
Report date August 31, 2026 · Filed September 02, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 52,035 |
Reported balance
After 2026-08-31 transaction · row 1
1 source rowRow 1 · 2026-08-31 · Tax withholding · Disposed 259 · Balance 52,035 F1: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units. |
| Common StockSEC Table I · non-derivative | IndirectBy Spouse | 15,870 |
Reported balance
Holding disclosure · report date 2026-08-31 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 15,870 |
| Common StockSEC Table I · non-derivative | IndirectBy Carolyn Short 2020 Irrevocable Gift Trust | 5,174 |
Reported balance
Holding disclosure · report date 2026-08-31 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 5,174 |
| Common StockSEC Table I · non-derivative | IndirectBy Jay Short 2020 Irrevocable Gift Trust | 5,174 |
Reported balance
Holding disclosure · report date 2026-08-31 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 5,174 |
| Common StockSEC Table I · non-derivative | IndirectBy Capia IP, LLC | 6,046 |
Reported balance
Holding disclosure · report date 2026-08-31 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 6,046 |
| Common StockSEC Table I · non-derivative | IndirectBy Himalaya Parent LLC | 1 |
Reported balance
Holding disclosure · report date 2026-08-31 · row 6
Holding and transaction disclosures are not merged.
1 source rowRow 6 · Balance 1 F2: The Reporting Person and his spouse are the managers of Himalaya Parent LLC and collectively make investment decisions on the behalf of the entity. The Reporting Person and his spouse disclaim beneficial ownership of the reported securities except to the extent of his or her pecuniary interest therein. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction is not a sale of shares by the Reporting Person. Instead, this represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the vesting and net settlement of previously reported restricted stock units.
F2: The Reporting Person and his spouse are the managers of Himalaya Parent LLC and collectively make investment decisions on the behalf of the entity. The Reporting Person and his spouse disclaim beneficial ownership of the reported securities except to the extent of his or her pecuniary interest therein.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 24, 2021 Filed Dec 1, 2021 01:04 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 4,859 | $25.77 | $125,221.29 |
DisclosureSEC source: 0001209191-21-067217 · doc4.xml · nonDerivative · entry 6 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,383,868 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F7 · price: The range of prices for the shares of Common Stock is from $25.57 to $26.14. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 24, 2021 Filed Dec 1, 2021 01:04 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 5,852 | $25.00 | $146,294.15 |
DisclosureSEC source: 0001209191-21-067217 · doc4.xml · nonDerivative · entry 5 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,388,727 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F6 · price: The range of prices for the shares of Common Stock is from $24.48 to $25.42. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 24, 2021 Filed Dec 1, 2021 01:04 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 6,311 | $24.05 | $151,798.48 |
DisclosureSEC source: 0001209191-21-067217 · doc4.xml · nonDerivative · entry 4 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,394,579 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F5 · price: The range of prices for the shares of Common Stock is from $23.48 to $24.32. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 23, 2021 Filed Dec 1, 2021 01:04 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 9,082 | $26.04 | $236,449.87 |
DisclosureSEC source: 0001209191-21-067217 · doc4.xml · nonDerivative · entry 3 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,400,890 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F4 · price: The range of prices for the shares of Common Stock is from $24.85 to $25.70. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 23, 2021 Filed Dec 1, 2021 01:04 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 15,861 | $24.29 | $385,184.39 |
DisclosureSEC source: 0001209191-21-067217 · doc4.xml · nonDerivative · entry 2 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,409,972 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F3 · price: The range of prices for the shares of Common Stock is from $23.82 to $24.79. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| November 22, 2021 Filed Dec 1, 2021 01:04 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 15,675 | $26.24 | $411,233.63 |
DisclosureSEC source: 0001209191-21-067217 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,425,833 F1 · kind: Represents shares of the Issuer's common stock sold by the reporting person to cover taxes due upon the release and settlement of the vested RSUs. F2 · price: The range of prices for the shares of Common Stock is from $25.83 to $26.75. The reporting person undertakes that he will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| August 24, 2021 Filed Aug 26, 2021 21:41 UTC | BioAtla, Inc. BCAB · Entity 879 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 7,747 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0001209191-21-053513 · doc4.xml · derivative · entry 7 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 0 Underlying: Common Stock · 7,747 shares Expires 2030-12-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: The option grant was reported by the Reporting Person's spouse on her Form 4 filed with the SEC on December 17, 2020. F3 · derivative.exercise_date: The Option is fully vested. Read SEC document |
| August 24, 2021 Filed Aug 26, 2021 21:41 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 4,533 | $41.60 | $188,572.80 |
DisclosureSEC source: 0001209191-21-053513 · doc4.xml · nonDerivative · entry 2 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 793,547 F1 · kind: Shares sold by the Reporting Person's spouse in payment of the aggregate option exercise price and withholding tax liability incurred upon the above-reported exercise of Option. F1 · shares: Shares sold by the Reporting Person's spouse in payment of the aggregate option exercise price and withholding tax liability incurred upon the above-reported exercise of Option. Read SEC document |
| August 24, 2021 Filed Aug 26, 2021 21:41 UTC | BioAtla, Inc. BCAB · Entity 879 | Exercise / conversionCommon Stock | 7,747 | $18.00 | $139,446.00 |
DisclosureSEC source: 0001209191-21-053513 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 798,080 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 07, 2021 Filed Jun 3, 2022 22:15 UTC | BioAtla, Inc. BCAB · Entity 879 | OtherCommon Stock | 5,378 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-034323 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,309,480 F1 · kind: These shares were received by the Reporting Person as part of a pro rata distribution-in-kind of Common Stock of the Issuer to the limited partners of an investment fund. Read SEC document |
| June 21, 2021 Filed Jun 22, 2021 23:39 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 1,700 | $39.89 | $67,819.97 |
DisclosureSEC source: 0001209191-21-042562 · doc4.xml · nonDerivative · entry 4 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 790,333 F2 · shares: Represents shares of the Issuer's common stock sold by the reporting person's spouse to cover taxes due upon the release and settlement of her 138,461 RSUs. F5 · price: The range of prices for the shares of Common Stock is from $39.83 to $40.09. The reporting person's spouse undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| June 21, 2021 Filed Jun 22, 2021 23:39 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 35,725 | $39.54 | $1,412,405.74 |
DisclosureSEC source: 0001209191-21-042562 · doc4.xml · nonDerivative · entry 3 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 792,033 F2 · shares: Represents shares of the Issuer's common stock sold by the reporting person's spouse to cover taxes due upon the release and settlement of her 138,461 RSUs. F4 · price: The range of prices for the shares of Common Stock is from $38.83 to $39.82. The reporting person's spouse undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| June 21, 2021 Filed Jun 22, 2021 23:39 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 17,575 | $38.24 | $672,147.09 |
DisclosureSEC source: 0001209191-21-042562 · doc4.xml · nonDerivative · entry 2 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 827,758 F2 · shares: Represents shares of the Issuer's common stock sold by the reporting person's spouse to cover taxes due upon the release and settlement of her 138,461 RSUs. F3 · price: The range of prices for the shares of Common Stock is from $37.83 to $38.82. The reporting person's spouse undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| June 17, 2021 Filed Jun 22, 2021 23:39 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 19,269 | $39.22 | $755,753.30 |
DisclosureSEC source: 0001209191-21-042562 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 845,333 F1 · price: The range of prices for the shares of Common Stock is from $39.00 to $39.62. The reporting person's spouse undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 01:22 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 4,068 | $40.08 | $163,058.46 |
DisclosureSEC source: 0001209191-21-041210 · doc4.xml · nonDerivative · entry 15 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 864,602 F10 · price: The range of prices for the shares of Common Stock is from $40.00 to $40.25. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| June 16, 2021 Filed Jun 17, 2021 01:22 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 31,349 | $39.33 | $1,232,858.99 |
DisclosureSEC source: 0001209191-21-041210 · doc4.xml · nonDerivative · entry 14 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 868,670 F9 · price: The range of prices for the shares of Common Stock is from $39.00 to $39.83. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 01:22 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 2 | $41.01 | $82.02 |
DisclosureSEC source: 0001209191-21-041210 · doc4.xml · nonDerivative · entry 13 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 900,019 Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 01:22 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 12,348 | $40.27 | $497,304.59 |
DisclosureSEC source: 0001209191-21-041210 · doc4.xml · nonDerivative · entry 12 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 900,021 F8 · price: The range of prices for the shares of Common Stock is from $40.00 to $40.99. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| June 15, 2021 Filed Jun 17, 2021 01:22 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 19,673 | $39.36 | $774,272.23 |
DisclosureSEC source: 0001209191-21-041210 · doc4.xml · nonDerivative · entry 11 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 912,369 F7 · price: The range of prices for the shares of Common Stock is from $39.00 to $39.97. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 01:22 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 1,807 | $44.47 | $80,364.88 |
DisclosureSEC source: 0001209191-21-041210 · doc4.xml · nonDerivative · entry 10 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 932,042 F6 · price: The range of prices for the shares of Common Stock is from $44.26 to $45.12. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 01:22 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 1,100 | $43.50 | $47,844.72 |
DisclosureSEC source: 0001209191-21-041210 · doc4.xml · nonDerivative · entry 9 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 933,849 F5 · price: The range of prices for the shares of Common Stock is from $43.25 to $44.19. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 01:22 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 3,070 | $42.24 | $129,691.84 |
DisclosureSEC source: 0001209191-21-041210 · doc4.xml · nonDerivative · entry 8 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 934,949 F4 · price: The range of prices for the shares of Common Stock is from $42.01 to $42.84. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 01:22 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 2,654 | $41.66 | $110,561.66 |
DisclosureSEC source: 0001209191-21-041210 · doc4.xml · nonDerivative · entry 7 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 938,019 F3 · price: The range of prices for the shares of Common Stock is from $41.00 to $41.98. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 01:22 UTC | BioAtla, Inc. BCAB · Entity 879 | SaleCommon Stock | 70,066 | $40.22 | $2,818,390.84 |
DisclosureSEC source: 0001209191-21-041210 · doc4.xml · nonDerivative · entry 6 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 940,673 F2 · price: The range of prices for the shares of Common Stock is from $40.00 to $40.95. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities sold at each separate price. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 01:22 UTC | BioAtla, Inc. BCAB · Entity 879 | OtherCommon Stock | 872,278 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-041210 · doc4.xml · nonDerivative · entry 5 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 1,010,739 F1 · kind: Distribution of the Issuer's shares of Common Stock by Himalaya Parent LLC, of which the reporting person is a member, for no consideration. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 01:22 UTC | BioAtla, Inc. BCAB · Entity 879 | OtherCommon Stock | 258,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-041210 · doc4.xml · nonDerivative · entry 4 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Carolyn Short 2020 Irrevocable Gift Trust Disclosed balance after: 258,727 F1 · kind: Distribution of the Issuer's shares of Common Stock by Himalaya Parent LLC, of which the reporting person is a member, for no consideration. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 01:22 UTC | BioAtla, Inc. BCAB · Entity 879 | OtherCommon Stock | 302,324 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-041210 · doc4.xml · nonDerivative · entry 3 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Capia IP, LLC Disclosed balance after: 302,324 F1 · kind: Distribution of the Issuer's shares of Common Stock by Himalaya Parent LLC, of which the reporting person is a member, for no consideration. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 01:22 UTC | BioAtla, Inc. BCAB · Entity 879 | OtherCommon Stock | 258,727 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-041210 · doc4.xml · nonDerivative · entry 2 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Jay Short 2020 Irrevocable Gift Trust Disclosed balance after: 258,727 F1 · kind: Distribution of the Issuer's shares of Common Stock by Himalaya Parent LLC, of which the reporting person is a member, for no consideration. Read SEC document |
| June 14, 2021 Filed Jun 17, 2021 01:22 UTC | BioAtla, Inc. BCAB · Entity 879 | OtherCommon Stock | 872,278 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-041210 · doc4.xml · nonDerivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,441,508 F1 · kind: Distribution of the Issuer's shares of Common Stock by Himalaya Parent LLC, of which the reporting person is a member, for no consideration. Read SEC document |
| December 15, 2020 Filed Dec 18, 2020 01:32 UTC | BioAtla, Inc. BCAB · Entity 879 | GrantEmployee Stock Option (right to buy) · Derivative | 30,988 | $0.00 Strike: $18.00 | $0.00 |
DisclosureSEC source: 0000899243-20-034346 · doc4.xml · derivative · entry 1 SHORT JAY M PHD · CIK 0001205375 · Director · Chief Executive Officer · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,988 Underlying: Common Stock · 30,988 shares Expires 2030-12-15 F1 · derivative.exercise_date: The option vests over a period of four years, with 25% of the shares underlying the option vesting on December 15, 2021, the first anniversary of the date of grant, and the remainder vesting in 36 substantially equal monthly installments thereafter, subject to the reporting person's continued employment through the applicable vesting dates. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.